Effect of Niacin in the Lipoprotein (a) Concentration

NCT01321034 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Niacin/Laropiprant

Sponsor

Instituto Aragones de Ciencias de la Salud

Collaborators

[object Object]